Global Parkinson Disease Drug Market Growth (Status and Outlook) 2023-2028

Report ID: 1162093 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Parkinson Disease Drug Market Size 2017-2028
        2.1.2 Parkinson Disease Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Parkinson Disease Drug Segment by Type
        2.2.1 Sinemet-CR
        2.2.2 Trastal
        2.2.3 Madopar
        2.2.4 COMT Inhibitor
        2.2.5 Other
    2.3 Parkinson Disease Drug Market Size by Type
        2.3.1 Parkinson Disease Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Parkinson Disease Drug Market Size Market Share by Type (2017-2022)
    2.4 Parkinson Disease Drug Segment by Application
        2.4.1 Under 40 Years Old
        2.4.2 40-65 Years Old
        2.4.3 Above 65 Years Old
    2.5 Parkinson Disease Drug Market Size by Application
        2.5.1 Parkinson Disease Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Parkinson Disease Drug Market Size Market Share by Application (2017-2022)
3 Parkinson Disease Drug Market Size by Player
    3.1 Parkinson Disease Drug Market Size Market Share by Players
        3.1.1 Global Parkinson Disease Drug Revenue by Players (2020-2022)
        3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2020-2022)
    3.2 Global Parkinson Disease Drug Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Parkinson Disease Drug by Regions
    4.1 Parkinson Disease Drug Market Size by Regions (2017-2022)
    4.2 Americas Parkinson Disease Drug Market Size Growth (2017-2022)
    4.3 APAC Parkinson Disease Drug Market Size Growth (2017-2022)
    4.4 Europe Parkinson Disease Drug Market Size Growth (2017-2022)
    4.5 Middle East & Africa Parkinson Disease Drug Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Parkinson Disease Drug Market Size by Country (2017-2022)
    5.2 Americas Parkinson Disease Drug Market Size by Type (2017-2022)
    5.3 Americas Parkinson Disease Drug Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Parkinson Disease Drug Market Size by Region (2017-2022)
    6.2 APAC Parkinson Disease Drug Market Size by Type (2017-2022)
    6.3 APAC Parkinson Disease Drug Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Parkinson Disease Drug by Country (2017-2022)
    7.2 Europe Parkinson Disease Drug Market Size by Type (2017-2022)
    7.3 Europe Parkinson Disease Drug Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Parkinson Disease Drug by Region (2017-2022)
    8.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2017-2022)
    8.3 Middle East & Africa Parkinson Disease Drug Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Parkinson Disease Drug Market Forecast
    10.1 Global Parkinson Disease Drug Forecast by Regions (2023-2028)
        10.1.1 Global Parkinson Disease Drug Forecast by Regions (2023-2028)
        10.1.2 Americas Parkinson Disease Drug Forecast
        10.1.3 APAC Parkinson Disease Drug Forecast
        10.1.4 Europe Parkinson Disease Drug Forecast
        10.1.5 Middle East & Africa Parkinson Disease Drug Forecast
    10.2 Americas Parkinson Disease Drug Forecast by Country (2023-2028)
        10.2.1 United States Parkinson Disease Drug Market Forecast
        10.2.2 Canada Parkinson Disease Drug Market Forecast
        10.2.3 Mexico Parkinson Disease Drug Market Forecast
        10.2.4 Brazil Parkinson Disease Drug Market Forecast
    10.3 APAC Parkinson Disease Drug Forecast by Region (2023-2028)
        10.3.1 China Parkinson Disease Drug Market Forecast
        10.3.2 Japan Parkinson Disease Drug Market Forecast
        10.3.3 Korea Parkinson Disease Drug Market Forecast
        10.3.4 Southeast Asia Parkinson Disease Drug Market Forecast
        10.3.5 India Parkinson Disease Drug Market Forecast
        10.3.6 Australia Parkinson Disease Drug Market Forecast
    10.4 Europe Parkinson Disease Drug Forecast by Country (2023-2028)
        10.4.1 Germany Parkinson Disease Drug Market Forecast
        10.4.2 France Parkinson Disease Drug Market Forecast
        10.4.3 UK Parkinson Disease Drug Market Forecast
        10.4.4 Italy Parkinson Disease Drug Market Forecast
        10.4.5 Russia Parkinson Disease Drug Market Forecast
    10.5 Middle East & Africa Parkinson Disease Drug Forecast by Region (2023-2028)
        10.5.1 Egypt Parkinson Disease Drug Market Forecast
        10.5.2 South Africa Parkinson Disease Drug Market Forecast
        10.5.3 Israel Parkinson Disease Drug Market Forecast
        10.5.4 Turkey Parkinson Disease Drug Market Forecast
        10.5.5 GCC Countries Parkinson Disease Drug Market Forecast
    10.6 Global Parkinson Disease Drug Forecast by Type (2023-2028)
    10.7 Global Parkinson Disease Drug Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Merck
        11.1.1 Merck Company Information
        11.1.2 Merck Parkinson Disease Drug Product Offered
        11.1.3 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Merck Main Business Overview
        11.1.5 Merck Latest Developments
    11.2 Akorn
        11.2.1 Akorn Company Information
        11.2.2 Akorn Parkinson Disease Drug Product Offered
        11.2.3 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Akorn Main Business Overview
        11.2.5 Akorn Latest Developments
    11.3 GSK
        11.3.1 GSK Company Information
        11.3.2 GSK Parkinson Disease Drug Product Offered
        11.3.3 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 GSK Main Business Overview
        11.3.5 GSK Latest Developments
    11.4 Novartis
        11.4.1 Novartis Company Information
        11.4.2 Novartis Parkinson Disease Drug Product Offered
        11.4.3 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Novartis Main Business Overview
        11.4.5 Novartis Latest Developments
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Information
        11.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Offered
        11.5.3 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Boehringer Ingelheim Main Business Overview
        11.5.5 Boehringer Ingelheim Latest Developments
    11.6 Teva Pharmaceutical
        11.6.1 Teva Pharmaceutical Company Information
        11.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Offered
        11.6.3 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Teva Pharmaceutical Main Business Overview
        11.6.5 Teva Pharmaceutical Latest Developments
    11.7 Abbvie
        11.7.1 Abbvie Company Information
        11.7.2 Abbvie Parkinson Disease Drug Product Offered
        11.7.3 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Abbvie Main Business Overview
        11.7.5 Abbvie Latest Developments
    11.8 Kyowa Hakko Kirin Pharma
        11.8.1 Kyowa Hakko Kirin Pharma Company Information
        11.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered
        11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Kyowa Hakko Kirin Pharma Main Business Overview
        11.8.5 Kyowa Hakko Kirin Pharma Latest Developments
    11.9 Astellas Pharma
        11.9.1 Astellas Pharma Company Information
        11.9.2 Astellas Pharma Parkinson Disease Drug Product Offered
        11.9.3 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Astellas Pharma Main Business Overview
        11.9.5 Astellas Pharma Latest Developments
    11.10 Desitin Arzneimittel
        11.10.1 Desitin Arzneimittel Company Information
        11.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Offered
        11.10.3 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Desitin Arzneimittel Main Business Overview
        11.10.5 Desitin Arzneimittel Latest Developments
    11. Endo Pharmaceuticals
        11.11.1 Endo Pharmaceuticals Company Information
        11.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Offered
        11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Endo Pharmaceuticals Main Business Overview
        11.11.5 Endo Pharmaceuticals Latest Developments
    11.12 F.Hoffmann-La Roche
        11.12.1 F.Hoffmann-La Roche Company Information
        11.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Offered
        11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 F.Hoffmann-La Roche Main Business Overview
        11.12.5 F.Hoffmann-La Roche Latest Developments
    11.13 H.Lundbeck
        11.13.1 H.Lundbeck Company Information
        11.13.2 H.Lundbeck Parkinson Disease Drug Product Offered
        11.13.3 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 H.Lundbeck Main Business Overview
        11.13.5 H.Lundbeck Latest Developments
    11.14 Valeant
        11.14.1 Valeant Company Information
        11.14.2 Valeant Parkinson Disease Drug Product Offered
        11.14.3 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Valeant Main Business Overview
        11.14.5 Valeant Latest Developments
    11.15 Apokyn
        11.15.1 Apokyn Company Information
        11.15.2 Apokyn Parkinson Disease Drug Product Offered
        11.15.3 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Apokyn Main Business Overview
        11.15.5 Apokyn Latest Developments
    11.16 Orion
        11.16.1 Orion Company Information
        11.16.2 Orion Parkinson Disease Drug Product Offered
        11.16.3 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Orion Main Business Overview
        11.16.5 Orion Latest Developments
    11.17 Stada Arzneimittel
        11.17.1 Stada Arzneimittel Company Information
        11.17.2 Stada Arzneimittel Parkinson Disease Drug Product Offered
        11.17.3 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Stada Arzneimittel Main Business Overview
        11.17.5 Stada Arzneimittel Latest Developments
    11.18 US WorldMeds
        11.18.1 US WorldMeds Company Information
        11.18.2 US WorldMeds Parkinson Disease Drug Product Offered
        11.18.3 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 US WorldMeds Main Business Overview
        11.18.5 US WorldMeds Latest Developments
    11.19 Bausch Health
        11.19.1 Bausch Health Company Information
        11.19.2 Bausch Health Parkinson Disease Drug Product Offered
        11.19.3 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 Bausch Health Main Business Overview
        11.19.5 Bausch Health Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Parkinson Disease Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Sinemet-CR
    Table 3. Major Players of Trastal
    Table 4. Major Players of Madopar
    Table 5. Major Players of COMT Inhibitor
    Table 6. Major Players of Other
    Table 7. Parkinson Disease Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Parkinson Disease Drug Market Size Market Share by Type (2017-2022)
    Table 10. Parkinson Disease Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Parkinson Disease Drug Market Size Market Share by Application (2017-2022)
    Table 13. Global Parkinson Disease Drug Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Parkinson Disease Drug Revenue Market Share by Player (2020-2022)
    Table 15. Parkinson Disease Drug Key Players Head office and Products Offered
    Table 16. Parkinson Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Parkinson Disease Drug Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Parkinson Disease Drug Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Parkinson Disease Drug Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Parkinson Disease Drug Market Size Market Share by Country (2017-2022)
    Table 23. Americas Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Parkinson Disease Drug Market Size Market Share by Type (2017-2022)
    Table 25. Americas Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Parkinson Disease Drug Market Size Market Share by Application (2017-2022)
    Table 27. APAC Parkinson Disease Drug Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Parkinson Disease Drug Market Size Market Share by Region (2017-2022)
    Table 29. APAC Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Parkinson Disease Drug Market Size Market Share by Type (2017-2022)
    Table 31. APAC Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Parkinson Disease Drug Market Size Market Share by Application (2017-2022)
    Table 33. Europe Parkinson Disease Drug Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Parkinson Disease Drug Market Size Market Share by Country (2017-2022)
    Table 35. Europe Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Parkinson Disease Drug Market Size Market Share by Type (2017-2022)
    Table 37. Europe Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Parkinson Disease Drug Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Parkinson Disease Drug Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Parkinson Disease Drug Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Parkinson Disease Drug Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Parkinson Disease Drug
    Table 46. Key Market Challenges & Risks of Parkinson Disease Drug
    Table 47. Key Industry Trends of Parkinson Disease Drug
    Table 48. Global Parkinson Disease Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Parkinson Disease Drug Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Parkinson Disease Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Parkinson Disease Drug Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Parkinson Disease Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Parkinson Disease Drug Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Merck Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 55. Merck Parkinson Disease Drug Product Offered
    Table 56. Merck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Merck Main Business
    Table 58. Merck Latest Developments
    Table 59. Akorn Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 60. Akorn Parkinson Disease Drug Product Offered
    Table 61. Akorn Main Business
    Table 62. Akorn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Akorn Latest Developments
    Table 64. GSK Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 65. GSK Parkinson Disease Drug Product Offered
    Table 66. GSK Main Business
    Table 67. GSK Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. GSK Latest Developments
    Table 69. Novartis Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 70. Novartis Parkinson Disease Drug Product Offered
    Table 71. Novartis Main Business
    Table 72. Novartis Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. Novartis Latest Developments
    Table 74. Boehringer Ingelheim Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 75. Boehringer Ingelheim Parkinson Disease Drug Product Offered
    Table 76. Boehringer Ingelheim Main Business
    Table 77. Boehringer Ingelheim Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. Boehringer Ingelheim Latest Developments
    Table 79. Teva Pharmaceutical Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 80. Teva Pharmaceutical Parkinson Disease Drug Product Offered
    Table 81. Teva Pharmaceutical Main Business
    Table 82. Teva Pharmaceutical Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. Teva Pharmaceutical Latest Developments
    Table 84. Abbvie Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 85. Abbvie Parkinson Disease Drug Product Offered
    Table 86. Abbvie Main Business
    Table 87. Abbvie Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. Abbvie Latest Developments
    Table 89. Kyowa Hakko Kirin Pharma Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 90. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered
    Table 91. Kyowa Hakko Kirin Pharma Main Business
    Table 92. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Kyowa Hakko Kirin Pharma Latest Developments
    Table 94. Astellas Pharma Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 95. Astellas Pharma Parkinson Disease Drug Product Offered
    Table 96. Astellas Pharma Main Business
    Table 97. Astellas Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. Astellas Pharma Latest Developments
    Table 99. Desitin Arzneimittel Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 100. Desitin Arzneimittel Parkinson Disease Drug Product Offered
    Table 101. Desitin Arzneimittel Main Business
    Table 102. Desitin Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 103. Desitin Arzneimittel Latest Developments
    Table 104. Endo Pharmaceuticals Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 105. Endo Pharmaceuticals Parkinson Disease Drug Product Offered
    Table 106. Endo Pharmaceuticals Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 107. Endo Pharmaceuticals Main Business
    Table 108. Endo Pharmaceuticals Latest Developments
    Table 109. F.Hoffmann-La Roche Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 110. F.Hoffmann-La Roche Parkinson Disease Drug Product Offered
    Table 111. F.Hoffmann-La Roche Main Business
    Table 112. F.Hoffmann-La Roche Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 113. F.Hoffmann-La Roche Latest Developments
    Table 114. H.Lundbeck Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 115. H.Lundbeck Parkinson Disease Drug Product Offered
    Table 116. H.Lundbeck Main Business
    Table 117. H.Lundbeck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 118. H.Lundbeck Latest Developments
    Table 119. Valeant Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 120. Valeant Parkinson Disease Drug Product Offered
    Table 121. Valeant Main Business
    Table 122. Valeant Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 123. Valeant Latest Developments
    Table 124. Apokyn Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 125. Apokyn Parkinson Disease Drug Product Offered
    Table 126. Apokyn Main Business
    Table 127. Apokyn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 128. Apokyn Latest Developments
    Table 129. Orion Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 130. Orion Parkinson Disease Drug Product Offered
    Table 131. Orion Main Business
    Table 132. Orion Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 133. Orion Latest Developments
    Table 134. Stada Arzneimittel Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 135. Stada Arzneimittel Parkinson Disease Drug Product Offered
    Table 136. Stada Arzneimittel Main Business
    Table 137. Stada Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 138. Stada Arzneimittel Latest Developments
    Table 139. US WorldMeds Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 140. US WorldMeds Parkinson Disease Drug Product Offered
    Table 141. US WorldMeds Main Business
    Table 142. US WorldMeds Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 143. US WorldMeds Latest Developments
    Table 144. Bausch Health Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors
    Table 145. Bausch Health Parkinson Disease Drug Product Offered
    Table 146. Bausch Health Main Business
    Table 147. Bausch Health Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 148. Bausch Health Latest Developments
List of Figures
    Figure 1. Parkinson Disease Drug Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Parkinson Disease Drug Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Parkinson Disease Drug Market Size Market Share by Type in 2021
    Figure 7. Parkinson Disease Drug in Under 40 Years Old
    Figure 8. Global Parkinson Disease Drug Market: Under 40 Years Old (2017-2022) & ($ Millions)
    Figure 9. Parkinson Disease Drug in 40-65 Years Old
    Figure 10. Global Parkinson Disease Drug Market: 40-65 Years Old (2017-2022) & ($ Millions)
    Figure 11. Parkinson Disease Drug in Above 65 Years Old
    Figure 12. Global Parkinson Disease Drug Market: Above 65 Years Old (2017-2022) & ($ Millions)
    Figure 13. Global Parkinson Disease Drug Market Size Market Share by Application in 2021
    Figure 14. Global Parkinson Disease Drug Revenue Market Share by Player in 2021
    Figure 15. Global Parkinson Disease Drug Market Size Market Share by Regions (2017-2022)
    Figure 16. Americas Parkinson Disease Drug Market Size 2017-2022 ($ Millions)
    Figure 17. APAC Parkinson Disease Drug Market Size 2017-2022 ($ Millions)
    Figure 18. Europe Parkinson Disease Drug Market Size 2017-2022 ($ Millions)
    Figure 19. Middle East & Africa Parkinson Disease Drug Market Size 2017-2022 ($ Millions)
    Figure 20. Americas Parkinson Disease Drug Value Market Share by Country in 2021
    Figure 21. Americas Parkinson Disease Drug Consumption Market Share by Type in 2021
    Figure 22. Americas Parkinson Disease Drug Market Size Market Share by Application in 2021
    Figure 23. United States Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Canada Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 25. Mexico Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Brazil Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 27. APAC Parkinson Disease Drug Market Size Market Share by Region in 2021
    Figure 28. APAC Parkinson Disease Drug Market Size Market Share by Application in 2021
    Figure 29. China Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Japan Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Korea Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Southeast Asia Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 33. India Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Australia Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Europe Parkinson Disease Drug Market Size Market Share by Country in 2021
    Figure 36. Europe Parkinson Disease Drug Market Size Market Share by Type in 2021
    Figure 37. Europe Parkinson Disease Drug Market Size Market Share by Application in 2021
    Figure 38. Germany Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 39. France Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 40. UK Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Italy Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Russia Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region in 2021
    Figure 44. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Type in 2021
    Figure 45. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application in 2021
    Figure 46. Egypt Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 47. South Africa Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Israel Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Turkey Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 50. GCC Country Parkinson Disease Drug Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Americas Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 52. APAC Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 53. Europe Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 54. Middle East & Africa Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 55. United States Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 56. Canada Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 57. Mexico Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 58. Brazil Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 59. China Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 60. Japan Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 61. Korea Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 62. Southeast Asia Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 63. India Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 64. Australia Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 65. Germany Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 66. France Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 67. UK Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 68. Italy Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 69. Russia Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 70. Spain Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 71. Egypt Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 72. South Africa Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 73. Israel Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 74. Turkey Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
    Figure 75. GCC Countries Parkinson Disease Drug Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Parkinson Disease Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Parkinson Disease Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Parkinson Disease Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports